73 related articles for article (PubMed ID: 7769485)
1. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
J Hypertens Suppl; 1994 Dec; 12(10):S153-7. PubMed ID: 7769485
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
J Hypertens Suppl; 1994 Nov; 12(9):S23-7. PubMed ID: 7884580
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes.
Shih NL; Cheng TH; Loh SH; Cheng PY; Wang DL; Chen YS; Liu SH; Liew CC; Chen JJ
Biochem Biophys Res Commun; 2001 Apr; 283(1):143-8. PubMed ID: 11322781
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Zhang SQ; Ding B; Guo ZG; Li YX
Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
[TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
16. [Molecular basis for cardiac functions].
Nagai R; Yamazaki T; Shiojima I; Yazaki Y
Rinsho Byori; 1993 Apr; 41(4):409-14. PubMed ID: 8350501
[TBL] [Abstract][Full Text] [Related]
17. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
[TBL] [Abstract][Full Text] [Related]
18. Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress.
Yamazaki T; Yazaki Y
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S43-7; discussion S49-50. PubMed ID: 10076920
[TBL] [Abstract][Full Text] [Related]
19. Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T; Komuro I; Yazaki Y
Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade.
Zierhut W; Studer R; Laurent D; Kästner S; Allegrini P; Whitebread S; Cumin F; Baum HP; de Gasparo M; Drexler H
Cardiovasc Res; 1996 May; 31(5):758-68. PubMed ID: 8763405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]